Screener
Eligibility screening
Gemcitabine and Carboplatin After Progression on Enfortumab Vedotin and Pembrolizumab in Advanced/Metastatic Urothelial Carcinoma
2 US sites in PA
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.